5-Bromo-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione, 95+%, 50mg

3-(2-Amino-6-(1-((6-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)pyrimidin-4-yl)-2-methylbenzonitrile, 98.0%, 5mg

2-Chloro-N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]acetamide, 95+%, 1g

Water, HPLC for Gradient Analysis, 2.5L

2-Decenoic acid, 10-hydroxy-, (2E)-, 95%, 100g

4-(Bromomethyl)benzo[b]thiophene, 97.0%, 1g

2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-, hydrochloride (1:1), 99%, 25g

tert-Butyl 4-amino-1H-indazole-1-carboxylate, 95.0%, 5g

2-Hydroxy-1,2-di(thiophen-2-yl)ethan-1-one, 97%, 250mg

3,6-Dichloropyridine-2-carboxylic acid, 95.0%, 500g

Ammonium oxalate, 98.0%, 500g

(S)-Methyl morpholine-3-carboxylate hydrochloride, 95.0%, 25g

2-Amino-1-(1-methyl-1 H -imidazol-2-yl)-ethanoldihydrochloride, 95.0%, 1g